|
US4464467A
(en)
*
|
1982-07-26 |
1984-08-07 |
Bristol-Myers Company |
Antitumor antibiotics produced by new streptomyces
|
|
GB9818730D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Collections of compounds
|
|
GB9818732D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Collection of compounds
|
|
ES2199200T3
(en)
|
1998-08-27 |
2004-02-16 |
Spirogen Limited |
PIRROLOBENZODIACEPINS.
|
|
US6909006B1
(en)
|
1999-08-27 |
2005-06-21 |
Spirogen Limited |
Cyclopropylindole derivatives
|
|
GB0226593D0
(en)
|
2002-11-14 |
2002-12-24 |
Consultants Ltd |
Compounds
|
|
GB0321295D0
(en)
|
2003-09-11 |
2003-10-15 |
Spirogen Ltd |
Synthesis of protected pyrrolobenzodiazepines
|
|
SI1720881T1
(en)
|
2004-03-01 |
2013-04-30 |
Spirogen Sarl |
11-hydroxy-5h-pyrrolos2,1-ccs1,4cbenzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepins
|
|
GB0404577D0
(en)
|
2004-03-01 |
2004-04-07 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
EP1723152B1
(en)
|
2004-03-09 |
2015-02-11 |
Spirogen Sàrl |
Pyrrolobenzodiazepines
|
|
GB0819095D0
(en)
|
2008-10-17 |
2008-11-26 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
CA2795349C
(en)
|
2010-04-15 |
2016-11-29 |
Seattle Genetics, Inc. |
Targeted pyrrolobenzodiazepine conjugates
|
|
GB201006340D0
(en)
|
2010-04-15 |
2010-06-02 |
Spirogen Ltd |
Synthesis method and intermediates
|
|
WO2011130616A1
(en)
|
2010-04-15 |
2011-10-20 |
Spirogen Limited |
Pyrrolobenzodiazepines used to treat proliferative diseases
|
|
EP2751120B1
(en)
|
2011-09-20 |
2018-08-22 |
MedImmune Limited |
Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates
|
|
JP6399930B2
(en)
|
2011-10-14 |
2018-10-03 |
シアトル ジェネティクス,インコーポレーテッド |
Pyrrolobenzodiazepine and target conjugates
|
|
MX341523B
(en)
|
2011-10-14 |
2016-08-24 |
Medimmune Ltd |
Pyrrolobenzodiazepines.
|
|
CA2850096C
(en)
|
2011-10-14 |
2018-07-03 |
Spirogen Sarl |
Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
|
|
CA2850264C
(en)
|
2011-10-14 |
2019-11-05 |
Spirogen Sarl |
Pyrrolobenzodiazepines
|
|
ES2945932T3
(en)
|
2011-10-14 |
2023-07-10 |
Seagen Inc |
Pyrrolobenzodiazepines and targeted conjugates
|
|
ES2530968T3
(en)
|
2012-10-12 |
2015-03-09 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CA2887895C
(en)
|
2012-10-12 |
2019-10-29 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine-anti-cd19 antibody conjugates
|
|
NZ745069A
(en)
|
2012-10-12 |
2019-05-31 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2014057114A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-anti-psma antibody conjugates
|
|
EP2906249B1
(en)
|
2012-10-12 |
2018-06-27 |
MedImmune Limited |
Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
|
|
TR201808051T4
(en)
|
2012-10-12 |
2018-06-21 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine antibody conjugates.
|
|
EP2906297B1
(en)
|
2012-10-12 |
2017-12-06 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
JP6270859B2
(en)
|
2012-10-12 |
2018-01-31 |
エイディーシー・セラピューティクス・エス・アー・エール・エルAdc Therapeutics Sarl |
Pyrrolobenzodiazepine-antibody conjugate
|
|
PT2906251T
(en)
|
2012-10-12 |
2017-12-04 |
Medimmune Ltd |
CONJUGATES OF PYRROLOBENZODIAZEPINA-ANTIBODY ANTI-CD22
|
|
EP3054983B1
(en)
|
2013-10-11 |
2019-03-20 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
US9956299B2
(en)
|
2013-10-11 |
2018-05-01 |
Medimmune Limited |
Pyrrolobenzodiazepine—antibody conjugates
|
|
GB201317981D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US9950078B2
(en)
|
2013-10-11 |
2018-04-24 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
JP6878287B2
(en)
|
2014-11-25 |
2021-05-26 |
アーデーセー セラピューティクス ソシエテ アノニム |
Pyrrolobenzodiazepine-antibody conjugate
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
ES2871001T3
(en)
|
2017-02-08 |
2021-10-28 |
Adc Therapeutics Sa |
Conjugates of pyrrolobenzodiazepines and antibodies
|
|
KR102189731B1
(en)
|
2017-04-18 |
2020-12-11 |
메드임뮨 리미티드 |
Pyrrolobenzodiazepine conjugate
|
|
MX2019012464A
(en)
|
2017-04-20 |
2019-12-11 |
Adc Therapeutics Sa |
Combination therapy with an anti-axl antibody-drug conjugate.
|
|
BR112019026564A2
(en)
|
2017-06-14 |
2020-06-30 |
Adc Therapeutics Sa |
dosing regimens for administration of an anti-cd19 adc
|
|
AU2018316532B2
(en)
|
2017-08-18 |
2022-11-24 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
KR102890251B1
(en)
|
2019-03-15 |
2025-11-25 |
메드임뮨 리미티드 |
Azetidobenzodiazepine dimers and conjugates comprising the same for use in the treatment of cancer
|